Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Gynecology

Free Subscription Articles published in Gynecol Oncol Retrieve available abstracts of 650 articles: HTML format

Single Articles

July 2008
1. LLORET M , Lara PC, Bordon E, Rey A, et al
   MVP expression is related to IGF1-R in cervical carcinoma patients treated by radiochemotherapy.
   Gynecol Oncol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. FUHRMAN CB , Kilgore J, LaCoursiere YD, Lee CM, et al
   Radiosensitization of cervical cancer cells via double-strand DNA break repair inhibition.
   Gynecol Oncol. 2008;110:93-8.
   PubMed     Related articles    Abstract available
   
   
   
3. TAYLOR DD , Gercel-Taylor C
   MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.
   Gynecol Oncol. 2008;110:13-21.
   PubMed     Related articles    Abstract available
   
   
   
4. ORR J JR , Kelley J 3rd, Dizon D, Escobar P, et al
   Society of gynecologic oncologists position paper: breast cancer care.
   Gynecol Oncol. 2008;110:7-12.
   PubMed     Related articles   
   
   
   
5. GOFF BA
   Quality measures in gynecologic cancers: what and when?
   Gynecol Oncol. 2008;110:3-4.
   PubMed     Related articles   
   
   
   June 2008
6. SALVADOR S , Rempel A, Soslow RA, Gilks B, et al
   Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
   Gynecol Oncol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. MORGAN MA , Darcy KM, Rose PG, Degeest K, et al
   Paclitaxel poliglumex and carboplatin as first-line therapy in ovarian, peritoneal or fallopian tube cancer: A phase I and feasibility trial of the Gynecologic Oncology Group.
   Gynecol Oncol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
8. JOHNSON CC , Kessel B, Riley TL, Ragard LR, et al
   The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial.
   Gynecol Oncol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. MARKMAN M
   Mandating prospectively defined endpoints for ovarian cancer phase 2 trials: A strategy to improve the quality of gynecologic cancer clinical research.
   Gynecol Oncol. 2008;.
   PubMed     Related articles   
   
   
   
10. BAYAS JM , Costas L, Munoz A
    Cervical cancer vaccination indications, efficacy, and side effects.
    Gynecol Oncol. 2008;.
    PubMed     Related articles   
    
    
    
11. PARK JY , Kim DY, Suh DS, Kim JH, et al
    Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: Oncologic safety and reproductive outcomes.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
12. GONZALEZ-MARTIN A , Gonzalez-Cortijo L, Carballo N, Garcia JF, et al
    The current role of neoadjuvant chemotherapy in the management of cervical carcinoma.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
13. PAHISA J , Alonso I, Torne A
    Vaginal approaches to fertility-sparing surgery in invasive cervical cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles   
    
    
    
14. HAVRILESKY LJ , Whitehead CM, Rubatt JM, Cheek RL, et al
    Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
15. COLEMAN RL
    The Gynecologic Oncology Group's role in the treatment of recurrent cervix cancer: Current clinical trials.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
16. YAMAN C , Habelsberger A, Tews G, Polz W, et al
    The role of three-dimensional volume measurement in diagnosing endometrial cancer in patients with postmenopausal bleeding.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
17. BRUN JL , Rouzier R, Uzan S, Darai E, et al
    External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: Clues for a simplified score.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
18. YOSHIZAKI T , Enomoto T, Fujita M, Ueda Y, et al
    Frequent inactivation of RUNX3 in endometrial carcinoma.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
19. KUMAR S , Shah JP, Bryant CS, Imudia AN, et al
    The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
20. LEFFERS N , Lambeck AJ, de Graeff P, Bijlsma AY, et al
    Survival of ovarian cancer patients overexpressing the tumour antigen p53 is diminished in case of MHC class I down-regulation.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
21. HAMMES LS , Tekmal RR, Naud P, Edelweiss MI, et al
    Up-regulation of VEGF, c-fms and COX-2 expression correlates with severity of cervical cancer precursor (CIN) lesions and invasive disease.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
22. HAMILTON CA , Maxwell GL, Chernofsky MR, Bernstein SA, et al
    Intraperitoneal bevacizumab for the palliation of malignant ascites in refractory ovarian cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
23. RICHARDSON DL , Seamon LG, Cohn DE
    Panniculectomy concurrent with anterior pelvic exenteration for recurrent cervical cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles   
    
    
    
24. PFAENDLER KS , Mwanahamuntu MH, Sahasrabuddhe VV, Mudenda V, et al
    Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: Lessons from the field.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
25. KONNER J , Schilder RJ, Derosa FA, Gerst SR, et al
    A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
26. PRESS JZ , Kenyon JA, Xue H, Miller MA, et al
    Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
27. DEL CAMPO JM , Prat A, Gil-Moreno A, Perez J, et al
    Update on novel therapeutic agents for cervical cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles   
    
    
    
28. CHAN KK , Tam KF, Tse KY, Ngan HY, et al
    The role of regular physical examination in the detection of ovarian cancer recurrence.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
29. KUMAR S , Morris RT, Malone JM Jr
    Relative mortality in the women over 60 years of age with cervical cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles   
    
    
    
30. LEATH CA IIII , Decherd ME, Wilder JL
    Panniculectomy concurrent with anterior pelvic exenteration for recurrent cervical cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles   
    
    
    
31. COHN DE , Hall NC, Povoski SP, Seamon LG, et al
    Novel perioperative imaging with (18)F-FDG PET/CT and intraoperative (18)F-FDG detection using a handheld gamma probe in recurrent ovarian cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
32. BEINER ME , Hauspy J, Rosen B, Murphy J, et al
    Radical vaginal trachelectomy vs. radical hysterectomy for small early stage cervical cancer: A matched case-control study.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
33. GOFF BA , Holmberg LA, Veljovich D, Kurland BF, et al
    Treatment of recurrent or persistent platinum-refractory ovarian, fallopian tube or primary peritoneal cancer with gemcitabine and topotecan A phase II trial of the Puget Sound Oncology Consortium.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
34. KAJIYAMA H , Shibata K, Suzuki S, Ino K, et al
    Is there any possibility of fertility-sparing surgery in patients with clear-cell carcinoma of the ovary?
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
35. QU D , Qu H, Fu M, Zhao X, et al
    Increased expression of Nlp, a potential oncogene in ovarian cancer, and its implication in carcinogenesis.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
36. GIL-MORENO A , Diaz-Feijoo B, Perez-Benavente A, Del Campo JM, et al
    Impact of extraperitoneal lymphadenectomy on treatment and survival in patients with locally advanced cervical cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles   
    
    
    
37. KUOPPALA T , Maenpaa J, Tomas E, Puistola U, et al
    Surgically staged high-risk endometrial cancer: Randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
38. GIATROMANOLAKI A , Bates GJ, Koukourakis MI, Sivridis E, et al
    The presence of tumor-infiltrating FOXP3(+) lymphocytes correlates with intratumoral angiogenesis in endometrial cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
39. TAO X , Hu W, Ramirez PT, Kavanagh JJ, et al
    Chemotherapy for recurrent and metastatic cervical cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles   
    
    
    
40. HENSLEY ML , Blessing JA, Mannel R, Rose PG, et al
    Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial.
    Gynecol Oncol. 2008;109:329-34.
    PubMed     Related articles    Abstract available
    
    
    
41. FLEMING G
    Gemcitabine/docetaxel--welcome to a new standard.
    Gynecol Oncol. 2008;109:313-5.
    PubMed     Related articles   
    
    
    
42. DORUM A , Tonstad S, Liavaag AH, Michelsen TM, et al
    Bilateral oophorectomy before 50 years of age is significantly associated with the metabolic syndrome and Framingham risk score: a controlled, population-based study (HUNT-2).
    Gynecol Oncol. 2008;109:377-83.
    PubMed     Related articles    Abstract available
    
    
    
43. HAMPL M , Deckers-Figiel S, Hampl JA, Rein D, et al
    New aspects of vulvar cancer: changes in localization and age of onset.
    Gynecol Oncol. 2008;109:340-5.
    PubMed     Related articles    Abstract available
    
    
    
44. THOMAS MB , Wright JD, Leiser AL, Chi DS, et al
    Clear cell carcinoma of the cervix: a multi-institutional review in the post-DES era.
    Gynecol Oncol. 2008;109:335-9.
    PubMed     Related articles    Abstract available
    
    
    May 2008
45. AHN HJ , Bae J, Lee S, Ko JE, et al
    Differential expression of clusterin according to histological type of endometrial carcinoma.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
46. PRETET JL , Jacquard AC, Saunier M, Clavel C, et al
    Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2/3 and invasive cervical cancer The EDiTH III study.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
47. GUDIPUDI DK , Hartzfeld K, Montemarano N, Del Priore G, et al
    Decreased breast cancer rates among women with choriocarcinoma.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
48. OFER L , Ofer G, Alon BA
    RE:"Office hysteroscopy and the risk of microscopic extrauterine spread in endometrial cancer"
    Gynecol Oncol. 2008;.
    PubMed     Related articles   
    
    
    
49. DEVINE KM , Smicun Y, Hope JM, Fishman DA, et al
    S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
50. FRUMOVITZ M , Ramirez PT, Levenback CF
    Lymphatic mapping and sentinel lymph node detection in women with cervical cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles   
    
    
    
51. ALBAREDA J , Herrera M, Lopez Salva A, Garcia Donas J, et al
    Sacral metastasis in a patient with endometrial cancer: Case report and review of the literature.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
52. RAMIREZ PT , Schmeler KM, Soliman PT, Frumovitz M, et al
    Fertility preservation in patients with early cervical cancer: Radical trachelectomy.
    Gynecol Oncol. 2008;.
    PubMed     Related articles   
    
    
    
53. CHAO A , Ho KC, Wang CC, Cheng HH, et al
    Positron emission tomography in evaluating the feasibility of curative intent in cervical cancer patients with limited distant lymph node metastases.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
54. BOREN T , Xiong Y, Hakam A, Wenham R, et al
    MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
55. GOTLIEB WH , Saumet J, Beauchamp MC, Gu J, et al
    In vitro metformin anti-neoplastic activity in epithelial ovarian cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
56. MURDOCH WJ , Van Kirk EA, Isaak DD, Shen Y, et al
    Progesterone facilitates cisplatin toxicity in epithelial ovarian cancer cells and xenografts.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
57. REN J , Peng Z, Yang K
    A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
58. MOORE RG , Brown AK, Miller MC, Badgwell D, et al
    Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
59. MOORE KN , Reid MS, Fong DN, Myers TK, et al
    Ovarian cancer in the octogenarian: Does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
60. RAMIREZ PT , Soliman PT, Schmeler KM, Reis RD, et al
    Laparoscopic and robotic techniques for radical hysterectomy in patients with early-stage cervical cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles   
    
    
    
61. CARLSON JW , Kauderer J, Walker JL, Gold MA, et al
    A randomized phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: A Gynecologic Oncology Group study.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
62. RAMIREZ PT , Schmeler KM, Milam MR, Slomovitz BM, et al
    Efficacy of letrozole in the treatment of recurrent platinum- and taxane-resistant high-grade cancer of the ovary or peritoneum.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
63. PAPADIMITRIOU CA , Bafaloukos D, Bozas G, Kalofonos H, et al
    Paclitaxel, epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: A Hellenic Co-operative Oncology Group (HeCOG) study.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
64. MILLER DS , Blessing JA, Bodurka DC, Bonebrake AJ, et al
    Evaluation of pemetrexed (Alimta, LY231514) as second line chemotherapy in persistent or recurrent carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
65. GOFF BA
    Surgical education: what role should gynecologic oncologists play?
    Gynecol Oncol. 2008;109:164-5.
    PubMed     Related articles   
    
    
    
66. BOYD J
    Whence epithelial ovarian carcinoma?
    Gynecol Oncol. 2008;109:161-3.
    PubMed     Related articles   
    
    
    
67. BERIWAL S , Coon D, Heron DE, Kelley JL, et al
    Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar carcinoma.
    Gynecol Oncol. 2008;109:291-5.
    PubMed     Related articles    Abstract available
    
    
    
68. SAMAMA B , Schaeffer C, Boehm N
    P16 expression in relation to human papillomavirus in liquid-based cervical smears.
    Gynecol Oncol. 2008;109:285-90.
    PubMed     Related articles    Abstract available
    
    
    
69. FOLKINS AK , Jarboe EA, Saleemuddin A, Lee Y, et al
    A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations.
    Gynecol Oncol. 2008;109:168-73.
    PubMed     Related articles    Abstract available
    
    
    
70. RIEDINGER JM , Eche N, Basuyau JP, Dalifard I, et al
    Prognostic value of serum CA 125 bi-exponential decrease during first line paclitaxel/platinum chemotherapy: a French multicentric study.
    Gynecol Oncol. 2008;109:194-8.
    PubMed     Related articles    Abstract available
    
    
    
71. KOHORN E
    Comments concerning Professor Michael Seckl's response to Dr Kohorn's letter.
    Gynecol Oncol. 2008;109:309.
    PubMed     Related articles   
    
    
    
72. KAFALI H
    HPV16 and increased risk of recurrence after treatment for CIN.
    Gynecol Oncol. 2008;109:309-10.
    PubMed     Related articles   
    
    
    
73. HUH WK , Roden RB
    The future of vaccines for cervical cancer.
    Gynecol Oncol. 2008;109.
    PubMed     Related articles    Abstract available
    
    
    
74. DOWNS LS , Smith JS, Scarinci I, Flowers L, et al
    The disparity of cervical cancer in diverse populations.
    Gynecol Oncol. 2008;109.
    PubMed     Related articles    Abstract available
    
    
    
75. BAZE C , Monk BJ, Herzog TJ
    The impact of cervical cancer on quality of life: a personal account.
    Gynecol Oncol. 2008;109.
    PubMed     Related articles   
    
    
    
76. MONK BJ , Herzog TJ
    The new era of cervical cancer prevention: HPV vaccination.
    Gynecol Oncol. 2008;109.
    PubMed     Related articles   
    
    
    
77. WRIGHT TC JR , Huh WK, Monk BJ, Smith JS, et al
    Age considerations when vaccinating against HPV.
    Gynecol Oncol. 2008;109.
    PubMed     Related articles    Abstract available
    
    
    
78. HERZOG TJ , Huh WK, Downs LS, Smith JS, et al
    Initial lessons learned in HPV vaccination.
    Gynecol Oncol. 2008;109.
    PubMed     Related articles    Abstract available
    
    
    
79. MYERS E , Huh WK, Wright JD, Smith JS, et al
    The current and future role of screening in the era of HPV vaccination.
    Gynecol Oncol. 2008;109.
    PubMed     Related articles    Abstract available
    
    
    April 2008
80. SINGH H , Jain M, Mittal B
    MMP-7 (-181A>G) promoter polymorphisms and risk for cervical cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
81. QUIROS RM , Valianou M, Kwon Y, Brown KM, et al
    Ovarian normal and tumor-associated fibroblasts retain in vivo stromal characteristics in a 3-D matrix-dependent manner.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
82. BANSAL N , Herzog TJ, Burke W, Cohen CJ, et al
    The utility of preoperative endometrial sampling for the detection of uterine sarcomas.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
83. DURRANT D , Richards JE, Walker WT, Baker KA, et al
    Mechanism of cell death induced by cis-3, 4', 5-trimethoxy-3'-aminostilbene in ovarian cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
84. BAEK WS , Kubba SV
    Cauda equina syndrome due to leptomeningeal carcinomatosis of the ovary.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
85. WENZEL L , Huang HQ, Cella D, Walker JL, et al
    Validation of FACT/GOG-AD subscale for ovarian cancer-related abdominal discomfort: A Gynecologic Oncology Group study.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
86. NIMEIRI HS , Oza AM, Morgan RJ, Friberg G, et al
    Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: A trial of the Chicago, PMH, and California Phase II consortia.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
87. BULL PHELPS SL , Schorge JO, Peyton MJ, Shigematsu H, et al
    Implications of EGFR inhibition in ovarian cancer cell proliferation.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
88. WONG JY , Huggins GS, Debidda M, Munshi NC, et al
    Dichloroacetate induces apoptosis in endometrial cancer cells.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
89. MORRIS R , Alvarez RD, Andrews S, Malone J, et al
    Topotecan weekly bolus chemotherapy for relapsed platinum-sensitive ovarian and peritoneal cancers.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
90. SUSUMU N , Sagae S, Udagawa Y
    Reply to Michael H.R. Eichbaum et al. "Adjuvant treatment of early-stage endometrial cancer: Which patient can benefit from chemotherapy?"
    Gynecol Oncol. 2008;.
    PubMed     Related articles   
    
    
    
91. WRIGHT JD , Tian C, Mutch DG, Herzog TJ, et al
    Carboplatin dosing in obese women with ovarian cancer: A Gynecologic Oncology Group study.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
92. LEE HP , Seo SS, Ryu SY, Kim JH, et al
    Phase II evaluation of CKD-602, a camptothecin analog, administered on a 5-day schedule to patients with platinum-sensitive or -resistant ovarian cancer.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
93. HARLEY I , Rosen B, Risch HA, Siminovitch K, et al
    Ovarian cancer risk is associated with a common variant in the promoter sequence of the mismatch repair gene MLH1.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
94. SANTILLAN A , Govan L, Zahurak ML, Diaz-Montes TP, et al
    Feasibility and economic impact of a clinical pathway for pap test utilization in Gynecologic Oncology practice.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
95. BRISTOW RE , Peiretti M, Zanagnolo V, Salani R, et al
    Transverse colectomy in ovarian cancer surgical cytoreduction: Operative technique and clinical outcome.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
96. KOTHARI R , Seamon L, Cohn D, Fowler J, et al
    Stage IV endometrial cancer after failed conservative management: A case report.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
97. CHAN JK , Teoh D, Hu JM, Shin JY, et al
    Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
98. PUCA R , Nardinocchi L, Pistritto G, D'Orazi G, et al
    Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
99. HENSLEY ML , Blessing JA, Degeest K, Abulafia O, et al
    Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study.
    Gynecol Oncol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
100. MAHAJAN NN
     Vesicovaginal fistula formation in patients with Stage IVA cervical carcinoma.
     Gynecol Oncol. 2008;.
     PubMed     Related articles   
     
     
     
101. ORR JW JR , Taylor PT Jr
     Surgical management of endometrial cancer: how much is enough?
     Gynecol Oncol. 2008;109:1-3.
     PubMed     Related articles   
     
     
     
102. YOUNG JL , Jazaeri AA, Darus CJ, Modesitt SC, et al
     Cyclooxygenase-2 in cervical neoplasia: a review.
     Gynecol Oncol. 2008;109:140-5.
     PubMed     Related articles    Abstract available
     
     
     
103. QUERLEU D , Ferron G, Rafii A, Bouissou E, et al
     Pelvic lymph node dissection via a lateral extraperitoneal approach: description of a technique.
     Gynecol Oncol. 2008;109:81-5.
     PubMed     Related articles    Abstract available
     
     
     
104. FAMBRINI M , Penna C, Pieralli A, Bussani C, et al
     PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia.
     Gynecol Oncol. 2008;109:59-64.
     PubMed     Related articles    Abstract available
     
     
     
105. MOORE RG , Robison K, Brown AK, DiSilvestro P, et al
     Isolated sentinel lymph node dissection with conservative management in patients with squamous cell carcinoma of the vulva: a prospective trial.
     Gynecol Oncol. 2008;109:65-70.
     PubMed     Related articles    Abstract available
     
     
     
106. ORR JW JR , Naumann WR, Escobar P
     "Attitude is a little thing that makes a big difference" Winston Churchill.
     Gynecol Oncol. 2008;109:147-51.
     PubMed     Related articles   
     
     
     
107. BARBERA L , Thomas G, Elit L, Covens A, et al
     Treating vulvar cancer in the new millennium: are patients receiving optimal care?
     Gynecol Oncol. 2008;109:71-5.
     PubMed     Related articles    Abstract available
     
     
     
108. BENEDER C , Fuechsel FG, Krause T, Kuhn A, et al
     The role of 3D fusion imaging in sentinel lymphadenectomy for vulvar cancer.
     Gynecol Oncol. 2008;109:76-80.
     PubMed     Related articles    Abstract available
     
     
     March 2008
109. DOWDY SC , Loewen RT, Aletti G, Feitoza SS, et al
     Assessment of outcomes and morbidity following diaphragmatic peritonectomy for women with ovarian carcinoma.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
110. BOUCHARDY C , Fernandez S, Merglen A, Usel M, et al
     Increased risk of second cancer among patients with ovarian borderline tumors.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
111. STRNAD P , Robova H, Skapa P, Pluta M, et al
     A prospective study of sentinel lymph node status and parametrial involvement in patients with small tumour volume cervical cancer.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
112. LEE J , Yoon YS, Chung JH
     Epigenetic silencing of the WNT antagonist DICKKOPF-1 in cervical cancer cell lines.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
113. MCALPINE JN , Hodgson EJ, Abramowitz S, Richman SM, et al
     The incidence and risk factors associated with postoperative delirium in geriatric patients undergoing surgery for suspected gynecologic malignancies.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
114. LI AJ , Scoles DR, Armstrong KU, Karlan BY, et al
     Androgen receptor cytosine-adenine-guanine repeat polymorphisms modulate EGFR signaling in epithelial ovarian carcinomas.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
115. FERRANDINA G , Ludovisi M, Corrado G, Carone V, et al
     Prognostic role of ca125 response criteria and RECIST criteria: Analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
116. LITKOUHI B , Litkouhi B, Fleming E, Welch WR, et al
     Overexpression of CEACAM6 in borderline and invasive mucinous ovarian neoplasms.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
117. SINGH RK , Lange TS, Kim KK, Shaw SK, et al
     A novel indole ethyl isothiocyanate (7Me-IEITC) with anti-proliferative and pro-apoptotic effects on platinum-resistant human ovarian cancer cells.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
118. CHOI M , Fuller CD, Thomas CR Jr, Wang SJ, et al
     Conditional survival in ovarian cancer: Results from the SEER dataset 1988-2001.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
119. SENGUPTA S , Michener CM, Escobar P, Belinson J, et al
     Ovarian cancer immuno-reactive antigen domain containing 1 (OCIAD1), a key player in ovarian cancer cell adhesion.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
120. 
     Abstracts of the 39th Annual Meeting of the Society of Gynecologic Oncologists, Tampa, Florida, USA, 9-12 March 2008.
     Gynecol Oncol. 2008;108.
     PubMed     Related articles   
     
     
     
121. IKEDA K , Tate G, Suzuki T, Mitsuya T, et al
     Coordinate expression of cytokeratin 8 and cytokeratin 17 immunohistochemical staining in cervical intraepithelial neoplasia and cervical squamous cell carcinoma: an immunohistochemical analysis and review of the literature.
     Gynecol Oncol. 2008;108:598-602.
     PubMed     Related articles    Abstract available
     
     
     
122. WOODS DC , Alvarez C, Johnson AL
     Cisplatin-mediated sensitivity to TRAIL-induced cell death in human granulosa tumor cells.
     Gynecol Oncol. 2008;108:632-40.
     PubMed     Related articles    Abstract available
     
     
     
123. FRUMOVITZ M , Gayed IW, Jhingran A, Euscher ED, et al
     Lymphatic mapping and sentinel lymph node detection in women with vaginal cancer.
     Gynecol Oncol. 2008;108:478-81.
     PubMed     Related articles    Abstract available
     
     
     
124. KOHORN E
     Letter in response to "The management and outcome of healthy women with a persistently elevated beta-hCG" by Palmieri et al.
     Gynecol Oncol. 2008;108:659.
     PubMed     Related articles   
     
     
     
125. LANDRUM LM , Skaggs V, Gould N, Walker JL, et al
     Comparison of outcome measures in patients with advanced squamous cell carcinoma of the vulva treated with surgery or primary chemoradiation.
     Gynecol Oncol. 2008;108:584-90.
     PubMed     Related articles    Abstract available
     
     
     
126. STROUP AM , Harlan LC, Trimble EL
     Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States.
     Gynecol Oncol. 2008;108:577-83.
     PubMed     Related articles    Abstract available
     
     
     February 2008
127. ALBERTS DS , Marth C, Alvarez RD, Johnson G, et al
     Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: Results from a prospectively designed analysis of pro
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
128. SHAH CA , Allison KH, Garcia RL, Gray HJ, et al
     Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: Association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
129. KONECNY GE , Agarwal R, Keeney GA, Winterhoff B, et al
     Claudin-3 and claudin-4 expression in serous papillary, clear-cell, and endometrioid endometrial cancer.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
130. PARK JY , Kim EN, Kim DY, Suh DS, et al
     Role of PET or PET/CT in the post-therapy surveillance of uterine sarcoma.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
131. MARIANI A , Dowdy SC, Cliby WA, Gostout BS, et al
     Prospective assessment of lymphatic dissemination in endometrial cancer: A paradigm shift in surgical staging.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
132. OEI AL , Sweep FC, Massuger LF, Olthaar AJ, et al
     Transient human anti-mouse antibodies (HAMA) interference in CA 125 measurements during monitoring of ovarian cancer patients treated with murine monoclonal antibody.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
133. ZEMPOLICH K , Fuhrman C, Milash B, Flinner R, et al
     Changes in gene expression induced by chemoradiation in advanced cervical carcinoma: A microarray study of RTOG C-0128.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
134. PECTASIDES D , Xiros N, Papaxoinis G, Pectasides E, et al
     Carboplatin and paclitaxel in advanced or metastatic endometrial cancer.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
135. VAN DE NIEUWENHOF HP , van der Avoort IA, Massuger LF, de Hullu JA, et al
     Letter to the editor concerning "Topical imiquimod can reverse vulvar intraepithelial neoplasia: A randomized, double blinded study." Gynecologic Oncology 107 (2007) 219-222.
     Gynecol Oncol. 2008;.
     PubMed     Related articles   
     
     
     
136. EICHBAUM MH , Sohn C
     Adjuvant treatment of early-stage endometrial cancer: Which patient can benefit from chemotherapy?
     Gynecol Oncol. 2008;.
     PubMed     Related articles   
     
     
     
137. AL MOUSTAFA AE
     Human cervical carcinomas and EGF-R tyrosine kinase inhibitors.
     Gynecol Oncol. 2008;.
     PubMed     Related articles   
     
     
     
138. MODESITT SC , Sill M, Hoffman JS, Bender DP, et al
     A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
139. MARTINO M , Rajaram L, Maxwell GL, Clarke-Pearson D, et al
     Combination prophylaxis for thromboembolism prevention among gynecologic oncology patients perioperatively.
     Gynecol Oncol. 2008;.
     PubMed     Related articles   
     
     
     
140. MANJUNATH AP
     Anatomic identification and functional outcomes of the nerve sparing Okabayashi radical hysterectomy.
     Gynecol Oncol. 2008;.
     PubMed     Related articles   
     
     
     
141. YAHATA T , Numata M, Kashima K, Sekine M, et al
     Conservative treatment of stage IA1 adenocarcinoma of the cervix during pregnancy.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
142. SOEDA S , Nakamura N, Ozeki T, Nishiyama H, et al
     Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
143. FUJII S
     Reply to Dr. Manjunath regarding "Anatomic identification and functional outcomes of the nerve sparing Okabayashi radical hysterectomy"
     Gynecol Oncol. 2008;.
     PubMed     Related articles   
     
     
     
144. MAGRINA JF , Kho RM, Weaver AL, Montero RP, et al
     Robotic radical hysterectomy: Comparison with laparoscopy and laparotomy.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
145. STAMMER K , Edassery SL, Barua A, Bitterman P, et al
     Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
146. LINCH M , Stavridi F, Hook J, Barbachano Y, et al
     Experience in a UK cancer centre of weekly paclitaxel in the treatment of relapsed ovarian and primary peritoneal cancer.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
147. FADER AN , Gruenigen VV, Gibbons H, Abushahin F, et al
     Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patients.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
148. FOX KV , Shah CA, Swisher EM, Garcia RL, et al
     An evaluation of cervical cancer in women age sixty and over.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
149. MUNN S
     Ovary volume: A reconsideration of "Ovarian volume related to age"
     Gynecol Oncol. 2008;.
     PubMed     Related articles   
     
     
     
150. AYHAN A , Gultekin M, Dursun P, Dogan NU, et al
     Metastatic lymph node number in epithelial ovarian carcinoma: does it have any clinical significance?
     Gynecol Oncol. 2008;108:428-32.
     PubMed     Related articles    Abstract available
     
     
     
151. VON GRUENIGEN VE , Courneya KS, Gibbons HE, Kavanagh MB, et al
     Feasibility and effectiveness of a lifestyle intervention program in obese endometrial cancer patients: A randomized trial.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
152. MACDONALD MC , Palmer JE, Hancock BW, Tidy JA, et al
     Diagnostic challenges in extrauterine epithelioid trophoblastic tumours: a report of two cases.
     Gynecol Oncol. 2008;108:452-4.
     PubMed     Related articles    Abstract available
     
     
     
153. GIL OD , Lee C, Ariztia EV, Wang FQ, et al
     Lysophosphatidic acid (LPA) promotes E-cadherin ectodomain shedding and OVCA429 cell invasion in an uPA-dependent manner.
     Gynecol Oncol. 2008;108:361-9.
     PubMed     Related articles    Abstract available
     
     
     
154. LEE WY , Huang SC, Hsu KF, Tzeng CC, et al
     Roles for hypoxia-regulated genes during cervical carcinogenesis: somatic evolution during the hypoxia-glycolysis-acidosis sequence.
     Gynecol Oncol. 2008;108:377-84.
     PubMed     Related articles    Abstract available
     
     
     
155. YOKOYAMA M , Noguchi M, Nakao Y, Ysunaga M, et al
     Antiproliferative effects of the major tea polyphenol, (-)-epigallocatechin gallate and retinoic acid in cervical adenocarcinoma.
     Gynecol Oncol. 2008;108:326-31.
     PubMed     Related articles    Abstract available
     
     
     
156. BASARAN A , Ayhan A
     Cancer of the vagina treated with wide local excision and modified Martius (labial) flap interposition.
     Gynecol Oncol. 2008;108:455-6.
     PubMed     Related articles   
     
     
     January 2008
157. TAYLOR SA , Marrinan CH, Liu G, Nale L, et al
     Combining the farnesyltransferase inhibitor lonafarnib with paclitaxel results in enhanced growth inhibitory effects on human ovarian cancer models in vitro and in vivo.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
158. LING B , Gao Z, Sun M, Sun F, et al
     Laparoscopic radical hysterectomy with vaginectomy and reconstruction of vagina in patients with stage I of primary vaginal carcinoma.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
159. BARTON CA , Hacker NF, Clark SJ, O'Brien PM, et al
     DNA methylation changes in ovarian cancer: Implications for early diagnosis, prognosis and treatment.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
160. MARKMAN M
     Evidence-based chemotherapy administration in advanced ovarian cancer: An impressive past, a disquieting present and an uncertain future.
     Gynecol Oncol. 2008;.
     PubMed     Related articles   
     
     
     
161. SPURDLE A , Webb P
     Re: Excess of early onset multiple myeloma in endometrial cancer probands and their relatives suggests common susceptibility.
     Gynecol Oncol. 2008;.
     PubMed     Related articles   
     
     
     
162. BLACK D , Levine DA, Nicoll L, Chou JF, et al
     Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
163. HOEKSTRA AV , Ward EC, Hardt JL, Lurain JR, et al
     Chemosensitization of endometrial cancer cells through AKT inhibition involves FOXO1.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
164. TAKAI N , Ueda T, Nishida M, Nasu K, et al
     beta-Hydroxyisovalerylshikonin has a profound anti-growth activity in human endometrial and ovarian cancer cells.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
165. RICHARD SD , Krivak TC, Castleberry A, Beriwal S, et al
     Survival for stage IB cervical cancer with positive lymph node involvement: a comparison of completed vs. abandoned radical hysterectomy.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
166. STEINER E , Pollow K, Hasenclever D, Schormann W, et al
     Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
167. KALLI KR , Oberg AL, Keeney GL, Christianson TJ, et al
     Folate receptor alpha as a tumor target in epithelial ovarian cancer.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
168. ZHOU B , Sun Q, Cong R, Gu H, et al
     Hormone replacement therapy and ovarian cancer risk: A meta-analysis.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
169. EINSTEIN MH , Hartenbach EM
     Venous thromboembolism prevention in gynecologic oncology.
     Gynecol Oncol. 2008;.
     PubMed     Related articles   
     
     
     
170. THOMAS GM , Aalders JG
     "Rational risk based nodal staging in endometrial cancer"
     Gynecol Oncol. 2008;.
     PubMed     Related articles   
     
     
     
171. TAKAC I , Zegura B
     Reply to Dr. Lavie, Dr. Gemer and Dr. Ben Arie regarding "Office hysteroscopy and the risk of microscopic extrauterine spread in endometrial cancer"
     Gynecol Oncol. 2008;.
     PubMed     Related articles   
     
     
     
172. PARK JY , Kim EN, Kim DY, Suh DS, et al
     Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
173. ALOUINI S , Rida K, Mathevet P
     Cervical cancer complicating pregnancy: Implications of laparoscopic lymphadenectomy.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
174. MARKMAN M
     Duration of second or greater complete clinical remission in ovarian cancer: Exploring potential endpoints for clinical trials.
     Gynecol Oncol. 2008;.
     PubMed     Related articles   
     
     
     
175. SABBATINI P , Harrison ML
     Response to Dr. Markman regarding "Duration of second or greater complete clinical remission in ovarian cancer: Exploring potential endpoints for clinical trials.
     Gynecol Oncol. 2008;.
     PubMed     Related articles   
     
     
     
176. SIRIAUNKGUL S , Suwiwat S, Settakorn J, Khunamornpong S, et al
     HPV genotyping in cervical cancer in Northern Thailand Adapting the linear array HPV assay for use on paraffin-embedded tissue.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
177. MOORE KN , Gold MA, McMeekin DS, Walker JL, et al
     Extraperitoneal para-aortic lymph node evaluation for cervical cancer via pfannenstiel incision: Technique and peri-operative outcomes.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
178. SECORD AA , Blessing JA, Armstrong DK, Rodgers WH, et al
     Phase II trial of cetuximab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growth factor receptor expression: A Gynecologic Oncology Group study.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
179. HOCHSTER H , Chen TT, Lu JM, Hills D, et al
     Tolerance and activity of oxaliplatin with protracted topotecan infusion in patients with previously treated ovarian cancer. A phase I study.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
180. BIEWENGA P , Buist MR, Moerland PD, van Themaat EV, et al
     Gene expression in early stage cervical cancer.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
181. BUTTIN BM , Moore MJ
     Thalidomide-induced reversible interstitial pneumonitis in a patient with recurrent ovarian cancer.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
182. LEE YK , Park NH, Kim JW, Song YS, et al
     Gamma-knife radiosurgery as an optimal treatment modality for brain metastases from epithelial ovarian cancer.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
183. OZBUDAK IH , Karaveli S, Simsek T, Erdogan G, et al
     Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
184. CACERES A , Zhou Q, Iasonos A, Gerdes H, et al
     Colorectal stents for palliation of large-bowel obstructions in recurrent gynecologic cancer: An updated series.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
185. WANG PH , Ko JL, Tsai HT, Yang SF, et al
     Clinical significance of matrix metalloproteinase-2 in cancer of uterine cervix: A semiquantitative study of immunoreactivities using tissue array.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
186. KENDRICK JE , Straughn JM Jr, Oliver PG, Wang W, et al
     Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
187. PARK JY , Lee KH, Dong SM, Kang S, et al
     The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
188. WATARI H , Ohta Y, Hassan MK, Xiong Y, et al
     Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
     Gynecol Oncol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
189. KARLAN BY
     Dawn of a new era for Gynecologic Oncology.
     Gynecol Oncol. 2008;108:2.
     PubMed     Related articles   
     
     
     
190. SONODA Y , Chi DS, Carter J, Barakat RR, et al
     Initial experience with Dargent's operation: the radical vaginal trachelectomy.
     Gynecol Oncol. 2008;108:214-9.
     PubMed     Related articles    Abstract available
     
     
     
191. NEDERGAARD BS , Ladekarl M, Nyengaard JR, Nielsen K, et al
     A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years.
     Gynecol Oncol. 2008;108:106-11.
     PubMed     Related articles    Abstract available
     
     
     
192. HIRAKAWA M , Nagai Y, Inamine M, Kamiyama K, et al
     Predictive factor of distant recurrence in locally advanced squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy.
     Gynecol Oncol. 2008;108:126-9.
     PubMed     Related articles    Abstract available
     
     
     
193. MAZIBRADA J , Ritta M, Mondini M, De Andrea M, et al
     Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis.
     Gynecol Oncol. 2008;108:112-20.
     PubMed     Related articles    Abstract available
     
     
     
194. NAGYMANYOKI Z , Callahan MJ, Parast MM, Berkowitz RS, et al
     Overexpression of laminin receptor 1 on decidual cells in partial and complete mole.
     Gynecol Oncol. 2008;108:121-5.
     PubMed     Related articles    Abstract available
     
     
     
195. HORN LC , Hentschel B, Galle D, Bilek K, et al
     Extracapsular extension of pelvic lymph node metastases is of prognostic value in carcinoma of the cervix uteri.
     Gynecol Oncol. 2008;108:63-7.
     PubMed     Related articles    Abstract available
     
     
     December 2007
196. PINKE DE , Kalloger SE, Francetic T, Huntsman DG, et al
     The prognostic significance of elongation factor eEF1A2 in ovarian cancer.
     Gynecol Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
197. SALANI R , Axtell A, Gerardi M, Holschneider C, et al
     Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer.
     Gynecol Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
198. FALCHOOK GS , Wolff RA, Varadhachary GR
     Clinicopathologic features and treatment strategies for patients with pancreatic adenocarcinoma and ovarian metastases.
     Gynecol Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
199. SONG SH , Lee JK, Lee NW, Saw HS, et al
     Interferon-gamma (IFN-gamma): A possible prognostic marker for clearance of high-risk human papillomavirus (HPV).
     Gynecol Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
200. SCHMELER KM , Sun CC, Bodurka DC, T Deavers M, et al
     Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum.
     Gynecol Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
201. ASHWORTH A , Balkwill F, Bast RC Jr, Berek JS, et al
     Opportunities and challenges in ovarian cancer research, a perspective from the 11th Ovarian cancer action/HHMT Forum, Lake Como, March 2007.
     Gynecol Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
202. THOMAS M , Mariani A, Wright JD, Madarek EO, et al
     Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: A multi-institutional review.
     Gynecol Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
203. GOLDBERG H , Miller RC, Abdah-Bortnyak R, Steiner M, et al
     Outcome after combined modality treatment for uterine papillary serous carcinoma: A study by the Rare Cancer Network (RCN).
     Gynecol Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
204. GUIRGUIS A , Elishaev E, Oh SH, Tseng GC, et al
     Use of gene expression profiles to stage concurrent endometrioid tumors of the endometrium and ovary.
     Gynecol Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
205. EDDY G
     Response to Sardi's comments on neoadjuvant chemotherapy in cervical cancer, by Eddy et al.
     Gynecol Oncol. 2007;.
     PubMed     Related articles   
     
     
     
206. SARDI JE
     Comments on neoadjuvant chemotherapy in cervical cancer.
     Gynecol Oncol. 2007;.
     PubMed     Related articles   
     
     
     
207. DELOIA JA , Zamboni WC, Jones JM, Strychor S, et al
     Expression and activity of taxane-metobolizing enzymes in ovarian tumors.
     Gynecol Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
208. EISENHAUER EL , Abu-Rustum NR, Sonoda Y, Aghajanian C, et al
     The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer.
     Gynecol Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
209. RISUM S , Hogdall C, Loft A, Berthelsen AK, et al
     Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography-A prospective study.
     Gynecol Oncol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
210. NAM JH
     Reply to Dr. P.-H. Wang regarding "Laparoscopic surgery for early-stage endometrial cancers"
     Gynecol Oncol. 2007;.
     PubMed     Related articles   
     
     
     
211. GERSHENSON DM
     Fallopian tube cancer: stepchild or mother?
     Gynecol Oncol. 2007;107:386-7.
     PubMed     Related articles   
     
     
     
212. STEWART SL , Wike JM, Foster SL, Michaud F, et al
     The incidence of primary fallopian tube cancer in the United States.
     Gynecol Oncol. 2007;107:392-7.
     PubMed     Related articles    Abstract available